![Barbara Domayne Hayman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Domayne Hayman
Miembro del Comité de Inversión en Cambridge Enterprise Ltd. .
Cargos activos de Barbara Domayne Hayman
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Miembro del Comité de Inversión | - | - |
Autifony Therapeutics Ltd.
![]() Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Historial de carrera de Barbara Domayne Hayman
Formación de Barbara Domayne Hayman.
University of Oxford | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Operativa
Investment Committee Member | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorial
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Finance |
Autifony Therapeutics Ltd.
![]() Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |